Reduced-intensity conditioning allogeneic stem cell transplantation in HIV patients with hematologic malignancies: Yes, we can

Blood

Volumn 114, Issue 12, 2009, Pages 2564-2566

  Hamadani, Mehdi ^a   Devine, Steven M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; BUSULFAN; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FLUDARABINE; LAMIVUDINE; METHOTREXATE; TACROLIMUS; TENOFOVIR; THYMOCYTE ANTIBODY; TIPRANAVIR; VIRUS RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; BURKITT LYMPHOMA; CANCER PATIENT; CASE REPORT; CHIMERA; DONOR LYMPHOCYTE INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOBLASTOMA; MALE; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS LOAD; ALLOTRANSPLANTATION; BLOOD DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; STEM CELL TRANSPLANTATION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 70350499490     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-229666     Document Type: Letter

References (6)

1. Angelucci E, Lucarelli G, Baronciani D, et al. Bone marrow transplantation in an HIV positive thalassemic child following therapy with azidothymidine. Haematologica. 1990;75:285-287. (Pubitemid 20273893)
2. Cooper MH, Maraninchi D, Gastaut JA, et al. HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population. J Acquir Immune Defic Syndr. 1993;6:277-284. (Pubitemid 23099731)
3. Bowden RA, Coombs RW, Nikora BH, et al. Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation. Am J Med. 1990;88:49N-52N.
4. Fernández-Avilés F, Urbano-Ispizua A, Aymerich M, et al. Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripheral blood. Leukemia. 2003;17:613-620. (Pubitemid 36395657)
5. Kang EM, de Witte M, Malech H, et al. Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome. Blood. 2002;99:698-701. (Pubitemid 34533111)
6. Woolfrey AE, Malhotra U, Harrington RD, et al. Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation. Blood. 2008;112:3484-3487.